TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76 | +300.0% | 10,900 | +1111.1% | 0.01% | +166.7% |
Q2 2023 | $19 | +171.4% | 900 | +50.0% | 0.00% | +200.0% |
Q1 2023 | $7 | -80.6% | 600 | -98.7% | 0.00% | -50.0% |
Q4 2022 | $36 | -98.8% | 45,700 | +6428.6% | 0.00% | – |
Q3 2022 | $3,000 | -62.5% | 700 | -88.1% | 0.00% | – |
Q2 2022 | $8,000 | -92.9% | 5,900 | -86.5% | 0.00% | -100.0% |
Q1 2022 | $112,000 | +20.4% | 43,837 | +76.6% | 0.01% | +50.0% |
Q4 2021 | $93,000 | -69.9% | 24,820 | -34.6% | 0.00% | -71.4% |
Q3 2021 | $309,000 | +173.5% | 37,940 | +254.6% | 0.01% | +133.3% |
Q2 2021 | $113,000 | +264.5% | 10,700 | +214.7% | 0.01% | +200.0% |
Q1 2021 | $31,000 | -73.0% | 3,400 | -75.3% | 0.00% | -66.7% |
Q4 2020 | $115,000 | +400.0% | 13,749 | +85.8% | 0.01% | +200.0% |
Q3 2020 | $23,000 | -84.1% | 7,400 | -51.0% | 0.00% | -77.8% |
Q2 2020 | $145,000 | – | 15,100 | +202.0% | 0.01% | – |
Q1 2020 | $0 | -100.0% | 5,000 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $9,000 | +800.0% | 5,000 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -87.5% | 5,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $8,000 | -20.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,000 | +66.7% | 5,000 | -52.1% | 0.00% | – |
Q4 2018 | $6,000 | -90.9% | 10,444 | -40.5% | 0.00% | -100.0% |
Q3 2018 | $66,000 | +1220.0% | 17,544 | +38.8% | 0.01% | – |
Q2 2018 | $5,000 | -90.2% | 12,644 | -14.2% | 0.00% | -100.0% |
Q1 2018 | $51,000 | +21.4% | 14,744 | -34.3% | 0.00% | +300.0% |
Q4 2017 | $42,000 | -68.4% | 22,426 | -54.7% | 0.00% | -80.0% |
Q3 2017 | $133,000 | +58.3% | 49,504 | -7.3% | 0.01% | +66.7% |
Q2 2017 | $84,000 | -40.4% | 53,391 | -38.7% | 0.00% | -50.0% |
Q1 2017 | $141,000 | +14000.0% | 87,120 | +21680.0% | 0.01% | – |
Q4 2016 | $1,000 | -66.7% | 400 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | +50.0% | 400 | -76.5% | 0.00% | – |
Q2 2016 | $2,000 | -99.0% | 1,700 | -91.7% | 0.00% | -100.0% |
Q1 2016 | $195,000 | +30.0% | 20,451 | -10.3% | 0.01% | +44.4% |
Q4 2015 | $150,000 | – | 22,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |